Skip to main content

LCD L38926: Cataract Extraction (including Complex Cataract Surgery)

LCD L38926, Cataract Extraction (including Complex Cataract Surgery), is the Local Coverage Determination that First Coast Service Options, Inc. applies to claims from 1 state plus 2 territories (FL, PR, VI), effective 2021-07-11. The policy text runs 981 words, and its billing and coding article A56647 lists 48 ICD-10-CM codes that support medical necessity for 7 procedure codes. 3 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 185 covered ICD-10-CM codes: 48 more codes than L35091 (Novitas Solutions, Inc., 137 codes, revised 2021-07-11) and 217 fewer codes than L33558 (Wellpoint Federal, 402 codes, revised 2026-04-01).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
First Coast Service Options, Inc.
States and territories
3
FL PR VI
Revision effective
2021-07-11
Original effective
2021-07-11
Policy text
981 words
Covered ICD-10 codes (articles)
185

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L38926
ContractContractorTypeStates
09101First Coast Service Options, Inc.A and B MACFL
09201First Coast Service Options, Inc.A and B MACPR VI
09102First Coast Service Options, Inc.A and B MACFL
09202First Coast Service Options, Inc.A and B MACPR
09302First Coast Service Options, Inc.A and B MACVI

Billing and coding articles A56647 and A58592: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56647 (Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)), Billing and Coding A58592 (Billing and Coding: Cataract Extraction (including Complex Cataract Surgery)) carry the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A56647: Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (Billing and Coding, effective 2023-10-07)

Covered ICD-10-CM codes
48
2 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
7
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A56647
ICD-10-CMDescription (FY2027)
H40.1111Primary open-angle glaucoma, right eye, mild stage
H40.1112Primary open-angle glaucoma, right eye, moderate stage
H40.1113Primary open-angle glaucoma, right eye, severe stage
H40.1114Primary open-angle glaucoma, right eye, indeterminate stage
H40.1121Primary open-angle glaucoma, left eye, mild stage
H40.1122Primary open-angle glaucoma, left eye, moderate stage
H40.1123Primary open-angle glaucoma, left eye, severe stage
H40.1124Primary open-angle glaucoma, left eye, indeterminate stage
H40.1131Primary open-angle glaucoma, bilateral, mild stage
H40.1132Primary open-angle glaucoma, bilateral, moderate stage
H40.1133Primary open-angle glaucoma, bilateral, severe stage
H40.1134Primary open-angle glaucoma, bilateral, indeterminate stage
H40.1211Low-tension glaucoma, right eye, mild stage
H40.1212Low-tension glaucoma, right eye, moderate stage
H40.1213Low-tension glaucoma, right eye, severe stage
H40.1214Low-tension glaucoma, right eye, indeterminate stage
H40.1221Low-tension glaucoma, left eye, mild stage
H40.1222Low-tension glaucoma, left eye, moderate stage
H40.1223Low-tension glaucoma, left eye, severe stage
H40.1224Low-tension glaucoma, left eye, indeterminate stage
H40.1231Low-tension glaucoma, bilateral, mild stage
H40.1232Low-tension glaucoma, bilateral, moderate stage
H40.1233Low-tension glaucoma, bilateral, severe stage
H40.1234Low-tension glaucoma, bilateral, indeterminate stage

Procedure codes: 0253T, 0449T, 0450T, 0474T, 0671T, 66989, 66991.

A58592: Billing and Coding: Cataract Extraction (including Complex Cataract Surgery) (Billing and Coding, effective 2025-10-01)

Covered ICD-10-CM codes
137
2 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
10
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A58592
ICD-10-CMDescription (FY2027)
E08.36Diabetes mellitus due to underlying condition with diabetic cataract
E09.36Drug or chemical induced diabetes mellitus with diabetic cataract
E10.36Type 1 diabetes mellitus with diabetic cataract
E11.36Type 2 diabetes mellitus with diabetic cataract
E13.36Other specified diabetes mellitus with diabetic cataract
H20.21Lens-induced iridocyclitis, right eye
H20.22Lens-induced iridocyclitis, left eye
H20.23Lens-induced iridocyclitis, bilateral
H21.221Degeneration of ciliary body, right eye
H21.222Degeneration of ciliary body, left eye
H21.223Degeneration of ciliary body, bilateral
H21.261Iris atrophy (essential) (progressive), right eye
H21.262Iris atrophy (essential) (progressive), left eye
H21.263Iris atrophy (essential) (progressive), bilateral
H21.271Miotic pupillary cyst, right eye
H21.272Miotic pupillary cyst, left eye
H21.273Miotic pupillary cyst, bilateral
H21.29Other iris atrophy
H21.531Iridodialysis, right eye
H21.532Iridodialysis, left eye
H21.533Iridodialysis, bilateral
H21.561Pupillary abnormality, right eye
H21.562Pupillary abnormality, left eye
H21.563Pupillary abnormality, bilateral

Procedure codes: 66840, 66850, 66852, 66920, 66940, 66982, 66983, 66984, 66987, 66988.

Coverage indications, limitations and medical necessity

Compliance with the provisions in this LCD may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Cataracts occur frequently as a progressive, age-related disease that is the leading cause of blindness in the U.S. and accounts for 50% of visual impairment over the age of 40. Cataracts are the leading cause of treatable blindness among African Americans age 40 and older. As part of the aging process, the lens increases in thickness and weight causing hardening and compression on the nucleus eventually developing a yellow-brown color that changes the transparency of the lens. Cataracts have several different types that have their own anatomical location, pathology, and risk factors (e.g., nuclear, cortical, subcapsular [anterior and posterior], and mixed).

Cataracts can lead to blurred or distorted vision, glare problems, color vision defects, and a decline of contrast sensitivity and depth perception. These impairments lead to loss of balance, less independent mobility, falls, injuries, increased mortality risk, and decreased mental well-being. This raises more concern for the elderly population due to underlying systemic comorbidities. Visual function plays a major role in physical performance, mental well-being, and mobility for the elderly. 1 Risk factors for cataracts include diabetes mellitus, family history, hypertension, ionizing radiation, myopia, obesity, smoking, ultraviolet-B light exposure, long-term topical, systemic, or oral corticosteroid use, prior intraocular surgery, and lower level education.

Improving visual function and quality of life have increased the demand for cataract surgery. Since there are no pharmacologic treatments to eliminate cataracts, cataract surgery is the primary management of significant visual impairment. 1 Due to the different types of cataracts, the decision-making process for cataract surgery can be complex in determining the appropriate treatment, technique, devices, and complications to consider. Symptomatic cataract is a surgical disease and the standard of care in cataract surgery in the U.S. is a small-incision phacoemulsification with foldable intraocular lens (IOL) implantation. 1

In consideration for cataract surgery, cataract patients must have an impairment of visual function due to cataract(s) resulting in the decreased ability to carry out activities of daily living such as reading, viewing television, driving or meeting occupational or vocational expectations. This LCD provides medically reasonable and necessary indications for both routine and complex cataract surgery. Coverage will be based upon documentation that supports medical necessity and therefore covered by Medicare when one or more of the covered indications are present.

Covered Indications

Cataract Surgery will be considered medically reasonable and necessary when one or more of the following indications are present:

• Visual function no longer meets the patient’s needs based on visual acuity, visual impairment, and potential for functional benefits. 2

• Visual Impairment and function are not correctable by glasses or other non-surgical measures. 3

• The patient has undergone a preoperative examination that documents the following:

• Inability to function satisfactorily due to visual impairment while performing various Activities of Daily Living. 1,2

• Confirmation that cataract is causing the visual impairment or other ocular or systemic conditions. 1

• Cataract is causing unacceptable glare, polyopia, or reduced quality of vision. 1-3

• There is clinically significant anisometropia in the presence of a cataract. 1,2

• The lens opacity interferes with optimal diagnosis or management of posterior segment conditions. 1,2

• The lens causes inflammation or secondary glaucoma (phacolysis, phaco-anaphylaxis). 1,2

• There is worsening angle closure (phacomorphic glaucoma) due to increase in size of the crystalline lens. 1,2

• A significant cataract is present in a patient who will be undergoing concurrent surgery in the same eye, such as a trabeculectomy or a corneal transplant when the surgeon deems that the decreased morbidity of single stage surgery is of significant benefit over surgery on separate dates. 1,2

Please refer to NCD 10.1-Use of Visual Tests Prior to and General Anesthesia During Cataract Surgery for information on pre surgery evaluations.

Complex cataract surgery :

Indications:

Complex cataract surgery will be considered medically reasonable and necessary when there is one of the following:

• A miotic pupil that will not dilate sufficiently 4 requirng the use of a mechanical iris expansion device (Iris retractors through four additional incisions, Beehler expansion device, or Malyugin ring) to adequately visualize the lens in the posterior chamber of the eye. 4

• Pre-existing zonular weakness requiring use of capsular tension rings or segments or intraocular suturing of the intraocular lens. 5

• Pediatric cataract surgery, intraoperatively difficult because of an anterior capsule that is more difficult to tear, cortex that is more difficult to remove needing a primary posterior capsulotomy or capsulorrhexis.

• Mature cataract requiring dye for visualization of capsulorrhexis.

Refer to CMS IOM Pub. 100-04, Medicare Claims Processing Manual , Chapter 32, Section 120, for CMS guidelines on IOL insertion benefit following cataract surgery.

Limitations

The following are considered contraindicators to surgery for visually impairing cataract and are not considered medically reasonable and necessary:

• Tolerable refractive correction that provides vision and meets the patient’s needs and desires. 2

• The patient’s lifestyle is not compromised by the cataract and they are able to perform activities of daily living. 1,2

• The patient cannot safely undergo surgery because of coexisting medical or ocular conditions. 1,2

• Surgery is not expected to improve visual function, or no other indication for lens removal exists. 1,2

Provider Qualifications

Services will be considered medically reasonable and necessary when all aspects of care are within the scope of practice of the provider’s professional licensure, when performed according to the supervision requirements per state scope of practice laws, and when all procedures are performed by appropriately trained providers in the appropriate setting.

Notice: Services performed for any given diagnosis must meet all of the indications and limitations stated in this LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.

Summary of evidence (opening)

The content of this LCD is supported through an evidence-based literature search of articles and publications through PubMed. We identified articles based on a key word search for: indications for complex cataract surgery, miotic pupil or small pupil in complex cataract surgery, and pseudoexfoliation in complex cataract surgery. The literature search was filtered to find articles within 5-10 years, with one exception where an article dated back to 2001. Filters also included full text articles, clinical trials, randomized controlled trials, and systematic reviews. Below is a summary of evidence to support the medically reasonable and necessary indications for Cataract Extraction (Including Complex Cataract Surgery) and explanation of limitations.

Michalska-Malecka, et al 3 conducted a study at University Hospital No. 5 of the Medical University of Silesia between 2008-2009. In this retrospective study, Michalaska-Malecka and his colleagues set out to investigate the effectiveness and safety of cataract surgery and IOL implantation for patients aged 90 years or older (43 men and 79 women). Patients considered for the study had significant bilateral cataracts causing visual impairment not correctable by glasses, best corrected visual acuity (BCVA) score worse than 0.7, an unacceptable glare, polyopia, or overall reduced vision quality due to cataracts. As this study focuses on the very elderly population, Michalska-Malecka noted that coexisting systemic disorders, patient cooperation during surgery, higher incidence of hard nucleus, smaller pupil size and high rate of pseudoexfoliation syndrome make it difficult to perform cataract surgery. Individuals that were excluded from the study were those that were under the age of 90, had a BCVA score of 0.7 or greater, a baseline endothelial cell density of less than 1,500 cells/mm, uncontrolled glaucoma, and physical or mental disability that would make it difficult to perform the surgery. According to Michalska-Malecka, cataracts are one of the most frequent reasons for visual impairment around the world. As cataracts and its visual impairment reduces quality of life, phacoemulsification surgery and extracapsular cataract extraction have proven to be effective with increasing visual acuity. In this study, phacoemulsification was performed on 113 of 122 eyes and extracapsular cataract extraction (ECCE) was performed on 9 of 122 eyes. Visual acuity was increased after the first postoperative day, 3 months, and 6 months after surgery. The BCVA scores improved in 100 out of the 122 patients (82%) with senile cataracts from this study. Visual acuity results remained the same in 20 of the patients and decreased in 2 of the patients because of co-existing age-related macular degeneration (AMD). The Intraocular pressure (IOP) in patients with or without glaucoma were shown to have little to no postoperative differences than preoperatively. Patients with glaucoma had a significant difference in IOP, postoperatively, while the patients without glaucoma had no difference. These results show that cataract surgery is safe and effective in the treatment of senile cataracts in the very elderly population. Michalaska-Malecka states, “Little evidence has been found to support the hypothesis that age alone is a risk factor for phaco-cataract surgery for intraoperative complications." 11

Bargoud et al 4 and colleagues conducted a retrospective, observational cohort study with the aim to see whether complex cataract surgery using the phacoemulsification technique and a mechanical iris expansion device (iris hooks, Kuglen hooks, and Malyugin rings) will lower IOP for patients with glaucoma. Bargoud 4 mentions the importance of this study in glaucoma patients with the modifiable risk factor of increased IOP. However, a significantly higher proportion of patients with glaucoma have been found to have smaller pupils compared with similar control groups, and on patients who underwent cataract surgery, they require iris manipulation and pupil expansion more frequently. This study was conducted at the University Hospital in Newark, New Jersey of surgeries from 2008-2016. The study was comprised of two groups: the primary open angle closure group and the control group that included patients without primary open-angle glaucoma (POAG) who underwent phacoemulsification with intraoperative mechanical pupillary expansion. Thirty-seven eyes from the 31 glaucoma patients (5 with mature cataracts) and 29 eyes from the 28 control patients (3 with mature cataracts) were included in the study and met the inclusion criteria. The other eyes in both groups had non-mature cataracts. Inclusion criteria focused on eyes that were diagnosed with POAG and had no prior incisional surgery for 1 year or 1 year after. Exclusion criteria included 1. eyes that had no confirmed glaucoma diagnosis, 2. had non-POAG types of glaucoma such as neovascular, uveitic, or chronic angle closure, 3. prior incisional glaucoma surgery, 4. eyes that had a phacoemulsification that was combined with another surgery and pupillary expansion devices was not confirmed from the operative report, and 5. had a vitrectomy, anterior chamber intraocular lens, and/or sulcus placement or conversion to large incisional surgery. The POAG group was significantly older than the control group at the time of surgery (72.5 ±10.2 versus 65.3 ±11.5 years old; p = 0.01). However, there were no significant differences in the proportions of hypertension, diabetes, or hyperlipidemia between the control and the POAG group. The study shows an increase 15.0 ± 4.6 to 15.9 ± 3.5 in IOP in the POAG group while the control group shows a decrease 14.1 ± 3.6 to 11.9 ± 3.9 at 12 months postoperative. Throughout the follow up period the control group showed significant decrease in IOP while the POAG group showed a significant decrease in mean antiglaucoma medication burden with improvement in visual acuity in both groups, more specifically the control group. More complications were noted in the POAG group than the control group. Complex cataract surgery did not decrease the IOP in patients with primary open angle glaucoma. However, it did improve visual acuity and reduced medication burden in the POAG group. Complex cataract surgery did, however, decrease IOP in patients without POAG and improve visual acuity. This study shows that complex cataract surgery, such as phacoemulsification with intraoperative mechanical pupillary expansion is useful in improvements of cataracts and glaucoma.

Miyoshi 5 and colleagues conducted a retrospective study to assess the effects of using the capsular tension ring (CTR) on the surgical outcomes of toric and multifocal IOLs in eyes with zonular instability. A total of 55 eyes from 43 patients (70.7 ± 10.3 years old) were included who were high risk for zonular instability that included pseudoexfoliation, shallow anterior chamber, high myopia, phacodonesis, or unstable zonules. A total of 55 eyes from 43 patients (70.7 ± 10.3 years old) were included in this retrospective study undergoing phacoemulsification and IOL implantation using CTR on toric and multifocal IOLs. These eyes were at high risk for zonular instability that included pseudoexfoliation, shallow anterior chamber, high myopia, phacodonesis, or unstable zonules. The Toric IOL group had 9 eyes with CTR and 22 eyes without CTR while the multifocal IOL had 9 eyes with CTR and 15 eyes without CTR. No history of ocular surgery other than cataract removal was reported. The exclusion criteria included any eyes that experienced intraoperative complications affecting the IOL stability, except for zonular instability. One surgeon performed all cases using a standard technique of phacoemulsification through a 2.4-mm temporal clear corneal incision. Patients were followed up for 3 months. Manifest refraction, refractive astigmatism, visual acuity, and degree of IOL decentration and tilt were measured using swept-source anterior segment optical coherence tomography. Axis misalignment of Toric IOLs was also evaluated. Results show that the decentration and axis misalignment of the Toric group was smaller with the CTR than without (p = 0.037), better visual acuity with CTR than without, and a smaller axis misalignment with CTR (p = 0.037). Although the multifocal group prevented IOL tilt, manifested better visual acuity with CTR than without (p = 0.021), and had a smaller degree of tilt in CTR than without (p = 0.025), the follow up period was longer with CTR. There were a few limitations in this study to include a random assignment of eyes to CTR or non-CTR by the judgement of the surgeon, the follow-up period was significantly longer in the multifocal IOL without CTR group than the multifocal IOL with CTR group, measurements of wave-front aberration were not conducted in this study, and no evaluation was done on the multifocal Toric IOLs. Overall, the end results show that the outcome of Toric IOLs co-implantation of CTR significantly reduce decentration and toxic axis misalignment that improves uncorrected and corrected visual acuity postoperatively. In multifocal IOLs, the combined use of CTR significantly prevented IOL tilt and resulted in better uncorrected visual acuity. This study shows that CTR is a useful device to improve surgical outcomes of premium IOL in eyes at high risk of compromised zonular integrity.

The contractor cites 18 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2021-07-11
Current revision effective
2021-07-11
MCD version
23

The contractor lists 4 National Coverage Determinations as related: NCD 10.1 Use of Visual Tests Prior to and General Anesthesia during Cataract Surgery, NCD 80.8 Endothelial Cell Photography, NCD 80.10 Phaco-Emulsification Procedure - Cataract Extraction, NCD 80.12 Intraocular Lenses (IOLs). Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Other related documents: A58765 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the First Coast Service Options, Inc. hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L38926 cover?

Cataracts occur frequently as a progressive, age-related disease that is the leading cause of blindness in the U.S. and accounts for 50% of visual impairment over the age of 40. Cataracts are the leading cause of treatable blindness among African Americans age 40 and older. As part of the aging process, the lens increases in thickness and weight causing hardening and compression on the nucleus eventually developing… The full 981-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L38926 apply to?

First Coast Service Options, Inc. applies it to Medicare claims in 1 state plus 2 territories: FL, PR, VI. It binds only that contractor; 3 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L38926?

The companion billing and coding article A56647 lists 48 ICD-10-CM codes in 2 groups that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L38926?

A denial under LCD L38926 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56647's 48 covered diagnosis codes, then file a redetermination with First Coast Service Options, Inc. within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.